Development of a machine learning model for precision prognosis of rapid kidney function decline in people with diabetes and chronic kidney disease

被引:1
|
作者
Lee, Woo Vin [1 ,2 ]
Song, Yuri [1 ,2 ]
Chun, Ji Sun [1 ,2 ]
Ko, Minoh [1 ,2 ]
Jang, Ha Young [1 ,2 ,3 ]
Kim, In-Wha [1 ,2 ]
Park, Sehoon [4 ]
Lee, Hajeong [4 ,5 ]
Lee, Hae-Young [4 ,5 ]
Kwak, Soo Heon [4 ,5 ]
Oh, Jung Mi [1 ,2 ,6 ]
机构
[1] Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro, Seoul 08826, South Korea
[3] Gachon Univ, Coll Pharm, 191 Hambangmoe Ro, Incheon 21565, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[6] Seoul Natl Univ, Nat Prod Res Inst, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea
基金
新加坡国家研究基金会;
关键词
Type; 2; diabetes; Chronic kidney disease; Rapid kidney function decline; Prognostic model; Explainable artificial intelligence; Copula simulation; PROTEINURIA; PROGRESSION; BILIRUBIN; ANEMIA;
D O I
10.1016/j.diabres.2024.111897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To develop a machine learning model for predicting rapid kidney function decline in people with type 2 diabetes (T2D) and chronic kidney disease (CKD) and to pinpoint key modifiable risk factors for targeted interventions. Methods: We conducted a retrospective cohort study on 6,924 individuals with T2D and CKD at Seoul National University Hospital. Kidney function decline was assessed using estimated glomerular filtration rate slopes. The performance of the eXtreme Gradient Boosting (XGBoost) model was evaluated through model diagnosis and time-to-event analyses. Copula simulation was conducted to stratify risk subgroups using modifiable risk factors. Results: A total of 906 (13.1 %) individuals experienced rapid kidney function decline. The XGBoost model demonstrated optimal performance (area under the receiver operating characteristic curve: 0.826). The hazard of end-stage kidney disease within eight years increased across risk quartiles, with statistically significant hazard ratios in Q3 (2.06; 95 % confidence interval [CI]: 1.29-3.29) and Q4 (10.9; 95 % CI: 7.36-16.2). Simulation analysis identified high-risk subgroups by stage A3 albuminuria and at least two of the following: haematocrit < 39.0 %, systolic blood pressure > 120 mmHg, and glycated hemoglobin A1c > 6.5 %. Conclusions: The XGBoost model, augmented by copula simulation, successfully stratified kidney prognosis in individuals with T2D and CKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association of sarcopenia with rapid kidney function decline and chronic kidney disease in adults with normal kidney function
    Zheng, Xiaowei
    Ren, Xiao
    Jiang, Minglan
    Han, Longyang
    Zhong, Chongke
    BRITISH JOURNAL OF NUTRITION, 2024, 131 (05) : 821 - 828
  • [2] Relation of uric acid level to rapid kidney function decline and development of kidney disease: The Jackson Heart Study
    Mwasongwe, Stanford E.
    Fulop, Tibor
    Katz, Ronit
    Musani, Solomon K.
    Sims, Mario
    Correa, Adolfo
    Flessner, Michael F.
    Young, Bessie A.
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (04) : 775 - 783
  • [3] Acute kidney injury in children with chronic kidney disease is associated with faster decline in kidney function
    Melhem, Nabil
    Rasmussen, Pernille
    Joyce, Triona
    Clothier, Joanna
    Reid, Christopher J. D.
    Booth, Caroline
    Sinha, Manish D.
    PEDIATRIC NEPHROLOGY, 2021, 36 (05) : 1279 - 1288
  • [4] Acute kidney injury in children with chronic kidney disease is associated with faster decline in kidney function
    Nabil Melhem
    Pernille Rasmussen
    Triona Joyce
    Joanna Clothier
    Christopher J. D. Reid
    Caroline Booth
    Manish D. Sinha
    Pediatric Nephrology, 2021, 36 : 1279 - 1288
  • [5] Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
    Conway, Baqiyyah N.
    Badders, Ashley N.
    Costacou, Tina
    Arthur, John M.
    Innes, Kim E.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 707 - 716
  • [6] Plasma metals, genetic risk, and rapid kidney function decline among type 2 diabetes
    Wang, Ruixin
    Cheng, Xu
    Long, Tengfei
    Jia, Chengyong
    Xu, Yali
    Wei, Yue
    Zhang, Ying
    He, Xiangjing
    He, Meian
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 946
  • [7] Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand
    Tuntayothin, Wilailuck
    Kerr, Stephen John
    Boonyakrai, Chanchana
    Udomkarnjananun, Suwasin
    Chukaew, Sumitra
    Sakulbumrungsil, Rungpetch
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 24 : 157 - 166
  • [8] Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease
    Provenzano, Michele
    Maritati, Federica
    Abenavoli, Chiara
    Bini, Claudia
    Corradetti, Valeria
    La Manna, Gaetano
    Comai, Giorgia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [9] Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension
    Hanratty, Rebecca
    Chonchol, Michel
    Dickinson, L. Miriam
    Beaty, Brenda L.
    Estacio, Raymond O.
    MacKenzie, Thomas D.
    Hurley, Laura P.
    Linas, Stuart L.
    Steiner, John F.
    Havranek, Edward P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (03) : 801 - 807
  • [10] Diabetes technology in people with diabetes and advanced chronic kidney disease
    Galindo, Rodolfo J.
    Soliman, Diana
    Chernasvvky, Daniel
    Rhee, Connie M.
    DIABETOLOGIA, 2024, 67 (10) : 2129 - 2142